Bone and soft tissue sarcomas, tumors of the skinBone and soft tissue sarcomas, tumors of the skinСаркомы костей, мягких тканей и опухоли кожи2219-46142782-3687Publishing House ABV Press249ArticlesСтатьиSOFT TISSUE SARCOMASСаркомы мягких тканейФеденкоА. А.Russian Federationfedenko@eesg.ruГорбуноваВ. А.Russian FederationFedenkoA. A.Russian FederationGorbunovaV. A.Russian FederationРоссийский онкологический научный центр им. Н.Н. Блохина РАМНN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences111120113431111012022Copyright ©; 2011, ., ., Fedenko A.A., Gorbunova V.A.Copyright ©; 2011, Феденко А.А., Горбунова В.А., Fedenko A., Gorbunova V.2011., ., Fedenko A.A., Gorbunova V.A.Феденко А.А., Горбунова В.А., Fedenko A., Gorbunova V.https://creativecommons.org/licenses/by/4.0https://sarbon.abvpress.ru/jour/article/view/249[Frustaci S., Gherlinzoni F., De Paoli A., Bonetti M., Azzarelli A., Comandone A., Olmi P., Buonadonna A., Pignatti G., Barbieri E., Apice G., Zmerly H., Serraino D., Picci P. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J. Clin. Oncol. 2001, Mar 1, v. 19 (5), p. 1238-1247.][Gossot D., Radu C., Girard P., Le Cesne A., Bonvalot S., Boudaya M.S., Validire P., Magdeleinat P. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann. Thorac. Surg. 2009, Jan., v. 87(1), p. 238-243.][Pfannschmidt J., Hoffmann H., Schneider T., Dienemann H. Pulmonary metastasectomy for soft tissue sarcomas: is it justified? Recent. Results Cancer Res. 2009, v. 179, p. 321-336.][Blackmon S.H., Shah N., Roth L.A., Correa A.M., Vaporciyan A.A, Rice D.C., Hofstetter W., Walsh G.L., Benjamin R., Pollock R., Swisher S.G., Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann. Thorac. Surg. 2009, Sep., v. 88 (3), p.877-884.][Demetri G.D., Chawla S.R, von Mehren M., Ritch P., Baker L.H., Blay J.Y., Hande K.R., Keohan M.L., Samuels B.L., Schuetze S., Lebedinsky C., Elsayed Y.A., Izquierdo M.A., Gomez J., Park Y.C., Le Cesne A. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J. Clin. Oncol. 2009, Sep. 1, v. 27 (25), p. 4188-4196.][Pacey S., Ratain M.J., Flaherty K.T., Kaye S.B., Cupit L., Rowinsky E.K., Xia C., O'Dwyer P.J., Judson I.R. Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial. Invest New Drugs. 2009 Dec. 18.][Stacchiotti S., Negri T., Zaffaroni N., Palassini E., Morosi C., Brich S., Conca E., Bozzi F., Cassinelli G., Gronchi A., Casali P.G., Pilotti S. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. Ann. Oncol. 2011, Jan 17.][Ganjoo K.N. New developments in targeted therapy for soft tissue sarcoma. Curr. Oncol. Rep. 2010, Jul, v. 12 (4), p. 261-265.]